Cleveland Clinic and SAS shared COVID-19 predictive models to help hospitals plan for current and future needs
On Apr. 21, 2020, to fight the novel coronavirus pandemic, Cleveland Clinic and SAS announced they had created…
Biotechnology | COVID-19 | Disease | FDA | Life Science News | Therapeutics
Novartis announced plan to initiate clinical study of Jakavi in severe COVID-19 patients
On Apr. 20, 2020, Novartis has reached an agreement with the FDA to proceed with a Phase III…
RedHill Biopharma announced agreement with NIAID to evaluate RHB-107 against COVID-19
On Apr. 20, 2020, RedHill Biopharma announced an agreement with the National Institute of Allergy and Infectious Diseases…
USC-LA County study showed early results of antibody testing suggest COVID-19 infections far exceeds number of confirmed cases in Los Angeles County
On Apr. 20, 2020, University of Southern California (USC) and the Los Angeles County Department of Public Health…
Oxford University project assessed Coronavirus infection rates in children and teenagers across UK
On Apr. 20, 2020, a multi-site project, called ‘What’s the STORY?’ received funding from UK Research and Innovation…
IDEXX made pet test for COVID-19 Virus available to veterinarians
On Apr. 20, 2020, IDEXX Labs announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR Test for pets….
Rice University COVID-19 research fund awarded first grants
On Apr. 20, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it will support…
Antiviral remdesivir prevented disease progression in monkeys with COVID-19
On Apr. 17, 2020, the NIH announced that early treatment with the experimental antiviral drug remdesivir significantly reduced…
FDA approved first new drug under international collaboration for patients with HER2-positive metastatic breast cancer
On Apr. 17, 2020, as part of Project Orbis, the U.S. Food and Drug Administration (FDA) approved Seagen’s…
Five Oxford University COVID-19 projects received UK Research and Innovation funding
On Apr. 17, 2020, five projects from across Oxford University’s Medical Sciences Division were among twenty-one new studies…
Roche developed new serology test to detect COVID-19 antibodies
On Apr. 17, 2020, Roche announced the development and upcoming launch of its Elecsys Anti-SARS-CoV-2 serology test to…
Kaiser Permanente Washington announced Coronavirus vaccine trial to include older people
On Apr. 17, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that older adults were being enrolled…
Sinovac announced commencement of phase I human clinical trial for vaccine candidate against COVID-19
On Apr. 17, 2020, Sinovac Biotech announced that the Company had commenced Phase I clinical trial, a randomized,…
FDA granted ExThera’s Seraph-100 blood filter Emergency Use Authorization for treatment of COVID-19 after promising results in europe and U.S.
On Apr. 17, 2020, after promising COVID-19 treatments in Germany, France, Italy, Spain and the U.S,, ExThera Medical’s…
Incyte announced initiation of phase 3 RUXCOVID study evaluating Ruxolitinib (Jakafi) as treatment for COVID-19 patients
On Apr. 17, 2020, Incyte announced the initiation of RUXCOVID, a global, randomized, double-blind, placebo-controlled phase 3 clinical…
Celdara Medical entered into a CRADA with USAMRIID and the Geneva Foundation
On Apr. 17, 2020, Celdara Medical announced that it had entered into a Cooperative Research and Development Agreement…
Slower clearance of Coronavirus infection may explain why men fare worse than women
On Apr. 17, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine may have solved…
OHSU received more than $11 million to continue brain, cognitive development research
On Apr. 17, 2020, the NIH announced nearly $290 million of new funding for seven years to research…
SeaGen announced FDA approval of TUKYSA (tucatinib) for people with advanced metastatic HER2-positive breast cancer
On Apr. 17, 2020, Seagen announced the FDA granted approval to TUKYSA (tucatinib) tablets in combination with trastuzumab…
University of Washington blood test detected past infections with new coronavirus
On Apr. 17, 2020, the University of Washington Medicine announced that a new clinical blood test will be…
Mayo Clinic prepared to commenced phase II FDA clinical trial for treatment of COVID-19 with Vicromax
On Apr. 16, 2020, BioSig Technologies announced that its subsidiary ViralClear Pharmaceuticals, had updated its clinical development program…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
Biogen, Broad Institute of MIT and Harvard, Partners HealthCare launched consortium to build and share a COVID-19 Biobank
On Apr. 16, 2020, Biogen, Broad Institute of MIT and Harvard, and Partners HealthCare announced a consortium that…
OpGen subsidiary Ares Genetics demonstrated feasibility and next generation sequencing based antibiotic susceptibility testing in multi-center study
On Apr. 16, 2020, OpGen announced that a study on the feasibility and potential of antibiotic susceptibility testing…
Atossa Therapeutics launched COVID-19 HOPE drug development program
On Apr. 16, 2020, Atossa Therapeutics announced a new drug development program called COVID-19 HOPE. The program used…
Landmark study of adolescent brain development renewed for additional seven years
On Apr. 15, 2020, the National Institutes of Health renewed its commitment to the Adolescent Brain Cognitive Development…
A gut-to-brain circuit drives sugar preference and may explain sugar cravings
On Apr. 15, 2020, Howard Hughes Medical Institute (HHMI) investigators report the sensation of sweetness starts on the…
Fujifilm accelerated production of its influenza antiviral drug ‘Avigan tablet’ for COVID-19
On Apr. 15, 2020, FUJIFILM announced that it hds expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co.,…
The Bill & Melinda Gates Foundation expands its commitment to global COVID-19 response
On Apr. 15, 2020, the Bill & Melinda Gates Foundation announced an expansion of its funding for the…
Todos Medical received medical importer status with U.S. FDA
On Apr. 15, 2020, Todos Medical announced the FDA has accepted Todos Medical’s application for Medical Device Establishment…
Penn Medicine launched national component of global registry to track exposures and outcomes among providers who intubate
On Apr. 15, 2020, a team at the Perelman School of Medicine at the University of Pennsylvania launched…